Background Giant prolactinomas are an unusual subset of macroprolactinomas and are
more commonly found in men. The goal of this review is to propose a giant prolactinoma …

Objective To review our experience with long-term cabergoline and bromocriptine therapy in
the treatment of giant prolactinomas. Methods Patients with giant prolactinomas diagnosed …

Giant prolactinomas (gPRLomas) are rare tumors of the lactotroph defined by an unusually
large size (> 4 cm) and serum PRL levels> 1000 ng/mL. The purpose of this study is to …

Summary objective The term 'giant prolactinoma'can be used for tumours larger than 4 cm in
diameter and/or with massive extrasellar extension. Cabergoline (CAB), a long‐lasting …

Objective: To describe outcomes of patients with giant prolactinoma (≥ 4 cm) and identify
predictors of therapeutic response. Methods: In this retrospective study, complete …

Purpose To describe the clinical presentation and treatment outcomes in a nationwide
cohort of patients with giant prolactinomas. Methods Register-based study of patients with …

Objective To review our experience with cabergoline, a D2-selective dopamine agonist, for
the treatment of giant prolactinomas. Design A retrospective case series; descriptive …

Giant prolactinomas are rare tumours, representing only 2–3% of all prolactin (PRL)-
secreting tumours and raising special diagnostic and therapeutic challenges. Based on …

The aim of the study was to evaluate the clinical features and long-term therapeutic outcome
of giant prolactinoma (gPRLoma) in men and to compare them with those of a group of male …

Prolactin-secreting adenomas (prolactinomas) are the most common secreting adenomas of
the pituitary. Microprolactinomas (diameter< 10 mm) are frequently diagnosed in women …